Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment

Cancer Chemotherapy and Pharmacology
Yoichi OzawaKentaro Yoshimatsu

Abstract

Indisulam (N-(-3-chloro-7-indolyl)-1,4-benzenedisulfonamide; E7070) is an experimental anticancer agent. Microarray analysis indicates that indisulam downregulates several genes involved in drug resistance, and this finding led us to test the effect of combining indisulam with other anticancer drugs. We investigated the antitumor effect and mechanism of synergism when indisulam was administered in combination with CPT-11. In vitro cytotoxic activity was examined using a cell counter kit, and the combination effect was determined by isobologram analysis. The level of topoisomerase IIα was measured by Western blotting. The in vivo antitumor effect was assessed in mice inoculated with human colorectal cancer SW620 cells. Isobologram analysis indicated that a 24-h exposure to indisulam and SN-38, an active metabolite of CPT-11, had a synergistic effect in HCT116 and SW620 cells and an additive effect in HCT15 and WiDr cells. Prolongation of exposure to 48 h resulted in a synergistic effect in HCT15 and WiDr cells. Treatment with SN-38 alone increased the amount of intracellular topoisomerase IIα in all cell lines tested. Co-treatment with indisulam suppressed the SN-38-induced upregulation of topoisomerase IIα after 24 h of exposur...Continue Reading

References

Jan 1, 1979·International Journal of Radiation Oncology, Biology, Physics·G G Steel, M J Peckham
Mar 12, 1992·International Journal of Cancer. Journal International Du Cancer·R KimK Okada
Dec 17, 1989·Biochimica Et Biophysica Acta·P D'Arpa, L F Liu
Jan 1, 1985·Annual Review of Biochemistry·J C Wang
Nov 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L RothenbergG I Rodriguez
May 29, 1998·Journal of Molecular and Cellular Cardiology·B K Slinker
Oct 3, 1999·Journal of Medicinal Chemistry·T OwaK Kitoh
Oct 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y OzawaK Yoshimatsu
Jul 20, 2002·Bioorganic & Medicinal Chemistry Letters·Takashi OwaKyosuke Kitoh
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E RaymondUNKNOWN European Organization for the Research and Treatment of Cancer Early Clinical Study Group
Jan 31, 2003·Expert Opinion on Investigational Drugs·Claudiu T Supuran
May 2, 2003·Analytical Chemistry·Yoshiya OdaTakeshi Nagasu
May 9, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TerretUNKNOWN EORTC Early Clinical Study Group
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J F SmythUNKNOWN EORTC New Drug Development and Melanoma Groups
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Denis C TalbotMartin Reck
Aug 5, 2009·World Journal of Gastroenterology : WJG·Jessica WeekesYik-Hong Ho
Apr 19, 2011·Clinical Medicine Insights. Oncology·Tatsuo KimuraKazuto Hirata

❮ Previous
Next ❯

Citations

Dec 22, 2015·The Journal of Organic Chemistry·Wucheng XieBaiquan Wang
May 14, 2016·Organic & Biomolecular Chemistry·Zengqiang Song, Andrey P Antonchick
Jun 27, 2018·Journal of Enzyme Inhibition and Medicinal Chemistry·Ahmed SabtLaila A Rashed
Mar 13, 2014·Chemistry : a European Journal·Changduo PanChengjian Zhu
Jan 10, 2018·Organic & Biomolecular Chemistry·Changduo PanJin-Tao Yu
Jul 29, 2021·Journal of Medicinal Chemistry·Guoqiang DongChunquan Sheng
Aug 16, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Ding ZhangQing Wang
Jun 23, 2021·Blood·Sisi ChenOmar Abdel-Wahab

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Investigational Drugs
Claudiu T Supuran
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Denis C TalbotMartin Reck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Ch Van KesterenEarly Clinical Studies Group of the European Organization for Research and Treatment of Cancer
© 2022 Meta ULC. All rights reserved